However, using IVT mRNAs, we verified that the production of GM-CSF by MSCs was within a specific range (1,48–2.09 μg/ml 2 × 105 MSCs), leading to significant inhibition of tumour growth in gastrointestinal tumour models. The gene discussed is CSF2; the disease is digestive system neoplasm.